A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for decades. Doctors are billing daraxonrasib as a “revolution” in cancer treatment, ...

Scientists at the world's largest cancer conference have hailed the start of a new drug 'revolution'.

A DAILY pill that can double pancreatic cancer survival time is the biggest breakthrough in decades, say doctors treating the ...

Researchers with the University of Cincinnati and Johns Hopkins Medicine developed a potential treatment for brain cancer ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have more reason to hope than ever before.

The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit explains why we are in a new era of progress against pancreatic ...

Less is more in the case of this cancer treatment. The most common form of cancer among men in the US, after skin cancer, ...

Cancer jab eradicates entire tumours in breakthrough trial - It shrank the tumours for 42 per cent of patients in the ...

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.

A cancer diagnosis changes how people measure time. This article explores how advances in oncology research, precision ...